Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: Shlepper who wrote (2501)	9/1/1998 8:40:00 PM
From: EZLibra	Respond to of 3702

Shep I'm surprised no one has answered you, they must be watching the Dow. Techniclone is not a component of it yet. TNT is undergoing proof of concept. In the glioma trial it can treat any brain cancer but is being utilized in the most difficult available population. Though the indication for this glioblastoma is small, on a relative basis for cancer, the overall incidence of brain cancer deaths in the U.S is over 40,000. Many other cancers metastasize to the brain cavity, such as lymphoma. Other trials will follow employing the same methodology and even Wall Street will eventually make the leap of faith which we have already done. I don't think it's a quantum leap.